Better breast cancer drug beats current gold standard
353967
A new drug is better than tamoxifen at preventing breast cancers from coming back and should immediately become the first-line treatment for women with certain tumours, researchers say.
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
728865
Novartis AG said on Wednesday that its  breast cancer pill Femara is more effective than the current  standard treatment tamoxifen in reducing the risk that the  cancer will return to older women after surgery.
563877
A new type of breast cancer drug is  clearly superior to the old standard, tamoxifen, in many women  and should now be the first drug used to treat the cancer, U.S.  and British researchers said on Wednesday.
163988
SAN ANTONIO Dec 8, 2004 - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
262390
A NEWER drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors in the US said yesterday, citing a new study.
638713
A new type of cancer drug being  developed by Bristol-Myers Squibb Co., when combined with a  standard chemotherapy, was significantly better than  chemotherapy alone in delaying progression of advanced breast  cancer, a researcher said on Sunday.
198053
Older women with early breast cancer should be put on a different drug to the current gold standard, say experts.
626533
GlaxoSmithKline Plc is preparing for a  "renaissance" of its oncology business, led by Tykerb, a novel  pill that is expected to win U.S. regulatory approval for  breast cancer next month.
62192
Arimidex has been shown to reduce the recurrence of breast cancer in women better than tamoxifen, the standard breast cancer therapy for postmenopausal women.
119927
A class of hormone-blocking drugs was more effective in preventing breast cancer recurrence in women past menopause than was a medication now prescribed by many doctors.
754325
NEW YORK  - After approximately 8 years, postmenopausal women with hormone-sensitive breast cancer who received (Arimidex), generically known as anastrazole, had a lower risk of recurrence than women taking tamoxifen, investigators reported at the annual meeting of the San Antonio Breast Cancer Symposium.
556150
TUESDAY, Jan. 30 (HealthDay News) -- A compound designed to block growth hormone, coupled with a standard chemotherapy drug, successfully treated human breast cancer in mice.
167586
SAN ANTONIO -- A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
145071
A drug used to treat breast cancer would not be good for preventing the tumours occurring in the first place, say researchers.
618283
WEDNESDAY, Oct. 17 (HealthDay News) -- A new chemotherapy drug called Ixempra has received U.S. Food and Drug Administration approval to treat women with advanced breast cancer who haven't responded to three other types of chemotherapy.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.